We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi
Product News

GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi

GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi
Product News

GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The new illustra Single Cell GenomiPhi DNA amplification kit from GE Healthcare Life Sciences provides a simple method for producing amplified genomic DNA reliably and reproducibly.

Delivering higher genome coverage with fewer mutations than PCR-based whole genome amplification methods, Single Cell GenomiPhi enables a more accurate representation of the original genome, giving researchers a tool that delivers increased confidence in results.

The amount of genomic DNA needed to carry out a full range of testing can represent significant challenges across numerous areas such as cancer, and environmental research. illustra Single Cell GenomiPhi has been optimized to wholly amplify genomic DNA from as little as a single cell, generating micrograms of high quality DNA for use in downstream applications.

Lysis reagents are optimized to fully release genomic DNA from the cell and subsequently denature the DNA to enable optimal amplification and coverage. Background amplification, often associated with multiple displacement amplification (MDA), is suppressed throughout the incubation so that only input DNA is amplified.

High quality reagents and an optional, proprietary enzymatic clean-up step in the protocol ensure that any potential DNA contaminants introduced during set-up are removed before each individual reaction.

In addition, manufacturing processes, including UV and enzymatic reagent cleanup, help to ensure that all kits are free from any detectable DNA contamination and enable sensitivity of amplification down to 1 fg of gDNA.

Advertisement